WF
TEVA icon

Welch & Forbes’s Teva Pharmaceuticals TEVA Stock Holding History

Welch & Forbes’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,100
Closed -$402K – 343
2017
Q2 		$402K Sell
12,100
-230
-2% -$7.12K 0.01% 266
2017
Q1 		$396K Sell
12,330
-1,120
-8% -$38.2K 0.01% 265
2016
Q4 		$487K Sell
13,450
-2,225
-14% -$88.8K 0.01% 244
2016
Q3 		$722K Sell
15,675
-366
-2% -$19.1K 0.03% 182
2016
Q2 		$805K Sell
16,041
-2,100
-12% -$112K 0.02% 204
2016
Q1 		$970K Buy
18,141
+400
+2% +$23.5K 0.03% 196
2015
Q4 		$1.17M Buy
17,741
+834
+5% +$51.5K 0.04% 182
2015
Q3 		$954K Sell
16,907
-5,680
-25% -$368K 0.03% 199
2015
Q2 		$1.33M Sell
22,587
-1,300
-5% -$80.2K 0.04% 191
2015
Q1 		$1.49M Sell
23,887
-2,618
-10% -$152K 0.04% 187
2014
Q4 		$1.52M Buy
26,505
+200
+0.8% +$11.1K 0.04% 185
2014
Q3 		$1.41M Sell
26,305
-4,550
-15% -$241K 0.04% 196
2014
Q2 		$1.62M Sell
30,855
-2,450
-7% -$125K 0.05% 176
2014
Q1 		$1.76M Sell
33,305
-3,160
-9% -$146K 0.06% 174
2013
Q4 		$1.46M Sell
36,465
-46,751
-56% -$1.84M 0.05% 179
2013
Q3 		$3.14M Sell
83,216
-64,773
-44% -$2.53M 0.11% 134
2013
Q2 		$5.8M Buy
+147,989
New +$5.76M 0.21% 105

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Welch & Forbes's TEVA Position: Q3 2017 in Review

Welch & Forbes sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 12,100 shares — an estimated $402K sold.

Welch & Forbes first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $5.8M in Q2 2013. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Welch & Forbes reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Welch & Forbes sold 12,100 Teva Pharmaceuticals shares in Q3 2017, an estimated $402K.
  • Welch & Forbes first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Welch & Forbes's Teva Pharmaceuticals position peaked at $5.8M in Q2 2013.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Welch & Forbes's 13F filing for Q3 2017, filed 13 Nov 2017.